Bellevue Asset Management »

Celldex Therapeutics shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $2.5M 160k 15.68
2015-09-30 $1.7M 160k 10.54
2015-06-30 $1.9M 74k 25.22
2015-03-31 $2.6M 104k 25.10